Congress orders study on brain-data privacy as neurotechnology expands
S. 2925 — MIND Act of 2025 · Filed by Chuck Schumer (D-NY) · 2 cosponsors · Introduced Sep 29, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Federal Trade Commission to study how neural data (information from brain-monitoring devices) and related biometric data are collected, used, and sold, and to recommend privacy protections and regulatory frameworks. It also requires the White House to develop guidance limiting how federal agencies can use neurotechnology, with a one-year implementation window.
Why we flagged it
The bill's core mechanism is a mandated FTC study followed by executive-branch guidance on neural data governance. It is not a direct regulation but a fact-finding and framework-development exercise intended to inform future policy on an emerging technology.
What the text implies
- The study's recommendations may form the basis for future FTC enforcement actions under existing consumer-protection statutes (FTC Act), potentially expanding the Commission's authority without explicit new rulemaking.
- Federal agency guidance on neurotechnology use may create de facto restrictions on procurement from companies whose practices do not align with the framework, indirectly shaping private-sector behavior without formal regulation.
The full analysis lists 5 implications of this text.
Who stands to gain
neurotechnology companies (device manufacturers, brain-computer interface firms); AI and machine-learning firms integrating neural data; data brokers and analytics firms specializing in biometric data